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Abstract
Background: Autism spectrum disorder (ASD) is a common and highly heritable neurodevelopmental disorder that
is likely to be the outcome of complex aetiological mechanisms. One strategy to provide insight is to study ASD
within tuberous sclerosis complex (TSC), a rare disorder with a high incidence of ASD, but for which the genetic
cause is determined. Individuals with ASD consistently demonstrate face processing impairments, but these have
not been examined in adults with TSC using event-related potentials (ERPs) that are able to capture distinct
temporal stages of processing.
Methods: For adults with TSC (n = 14), 6 of which had a diagnosis of ASD, and control adults (n = 13) passively
viewed upright and inverted human faces with direct or averted gaze, with concurrent EEG recording. Amplitude
and latency of the P1 and N170 ERPs were measured.
Results: Individuals with TSC + ASD exhibited longer N170 latencies to faces compared to typical adults.
Typical adults and adults with TSC-only exhibited longer N170 latency to inverted versus upright faces, whereas
individuals with TSC + ASD did not show latency differences according to face orientation. In addition, individuals
with TSC + ASD showed increased N170 latency to averted compared to direct gaze, which was not demonstrated
in typical adults. A reduced lateralization was shown for the TSC + ASD groups on P1 and N170 amplitude.
Conclusions: The findings suggest that individuals with TSC + ASD may have similar electrophysiological abnormalities
to idiopathic ASD and are suggestive of developmental delay. Identifying brain-based markers of ASD that are similar in
TSC and idiopathic cases is likely to help elucidate the risk pathways to ASD.
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Background
Autism spectrum disorder (ASD) is a common childhood-
onset disorder characterized by social and communication
impairments and restricted/repetitive behaviours and in-
terests. Family and twin studies indicate that genetic fac-
tors play an important role in the aetiology of ASD, but
non-genetic factors are also likely to be relevant in caus-
ation [1–3]. Molecular genetic studies have identified a
number of copy numbers and rare variants that underlie
genetic risk in a substantial minority of cases [4, 5].
Genome-wide association studies indicate that other more
common variants likely play a role, but the studies re-
ported to date are underpowered to confidently identify
the major variants involved [6, 7]. Nevertheless, the find-
ings to date are helping to identify putative neurobio-
logical processes involved in aetiology, with a major focus
on the genes involved in synaptic development and func-
tion [8]. Neuroimaging studies have also begun to
chart the structural and functional correlates of ASD,
but findings have been rather inconsistent, possibly
reflecting clinical and underlying genetic heterogen-
eity. One strategy to address the problem of genetic het-
erogeneity is to study syndromic model systems of ASD
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where the genetic cause is constrained. Tuberous sclerosis
complex (TSC) is a multi-systemic disorder caused by a
mutation in TSC1 on chromosome 9q34 or TSC2 on
chromosome 16p13.3. Individuals with mutations in the
TSC genes develop a variable and diverse array of physical,
cognitive and behavioural manifestations [9]. Remarkable
progress has been made with regard to clarifying the mo-
lecular biology of TSC, and this has led to extremely
promising new treatment approaches [10–12].
Several studies have shown that autistic behaviours
are frequently observed [13, 14], and between 30 and
60 % of individuals with TSC meet diagnostic criteria
for ASD [9, 15–17]. It is likely, therefore, that there
are specific risk mechanisms that determine which in-
dividuals develop ASD [18]. To shed light on the gene-
brain-behaviour risk pathways, an important approach is
to examine brain-based candidate biomarkers. In particu-
lar, event-related potentials (ERPs) are able to capture fast-
occurring altered cognitive processes in individuals of
different ages and abilities and thus are suitable for identi-
fying biomarkers of complex neurodevelopmental disor-
ders [19–23]. In order to identify these risk factors, it is
important to demonstrate that syndromic ASD (occurring
within a syndrome such as TSC) is the same as idiopathic
ASD, by examining a domain that is known to be altered
in the latter. A strong candidate biomarker of ASD is im-
pairment in the ability to process information from the
face, associated with activity in temporal brain regions.
Findings from ERP studies indicate abnormal responses to
face stimuli in ASD, notably a delayed ‘face-sensitive’ N170
[24], a reduction or absence of the face inversion effect on
the visual P1 and N170 amplitude [24–34] and altered pro-
cessing of gaze direction on the N170 [21, 35, 36]. Abnor-
mal ERP responses to gaze direction are also observed in
infant siblings of children with ASD [37, 38] and are pre-
dictive of subsequent ASD diagnosis [37]. In addition,
while the N170 is larger in the right hemiscalp compared
to the left hemiscalp in typically developing individuals, in-
dividuals with autism show an atypical bilateral scalp distri-
bution [24, 29, 36, 39] suggestive of abnormal cortical
specialization for faces [27]. Altered processing of faces
may contribute to the social impairments characterizing
the disorder such as impaired eye contact, joint attention
and theory of mind, which suggests it is a key brain-based
biomarker of risk for ASD.
Given that previous findings suggest an association
between the presence of tubers in the temporal regions
associated with face processing and risk of ASD in TSC
[40], there is relatively little work examining whether the
same neurophysiological correlates of impaired face pro-
cessing operate in syndromic ASD. A study of young
children with TSC reported delayed N290 (the develop-
mental ‘precursor’ to the N170) and reduced lateralization,
effects that were particularly pronounced in children with
a diagnosis of ASD [41]. There has not, however, been an
investigation of electrophysiological responses to changes
in face orientation and gaze direction in adults with TSC.
The current study aimed to examine neurophysio-
logical responses to faces and eye gaze in adults with
TSC with and without a diagnosis of ASD, compared to
typical adult controls, using a paradigm that has been
used in several previous studies of ASD [21, 35, 42, 43].
On the basis of previous work, it was hypothesized that
neurophysiological responses to faces would differ in
TSC + ASD compared to controls. Specifically, we pre-
dicted that adults with TSC + ASD would show (1) slo-
wed processing of faces, (2) a reduced effect of face
orientation and (3) altered processing of gaze direction.
Methods
Participants
Typical control adults (n = 13, male n = 11) and adults
with TSC (n = 14, male n = 9) were recruited for the
study. Participants with TSC underwent a multidiscip-
linary clinical assessment, and six participants (male
n = 5) were given a clinical diagnosis of ASD accord-
ing to DSM-IV criteria. Participants were aged 16–
46 years (mean age = 26.85, SD = 7.29); there were no
significant differences in age or gender proportions
between groups (Table 1). Intellectual ability was
measured using different tools depending on the abil-
ity level of the participant (Vineland Adaptive Behav-
iour Scales, Wechsler Intelligence Scale for Children,
Wechsler Adult Intelligence Scale, Raven’s matrices,
Table 1 Demographic and clinical characteristics
Controls TSC TSC + ASD
Age (SD) 29.77 (5.67) 25.50 (8.52) 22.33 (6.92) n.s.d.
Gender (male, %) 85 50 83 n.s.d.
IQ (SD) All >70 88.29 (13.64) 53.33 (30.82) F = 7.40, p = .02
Current epilepsy n/a 25 % 50 % n.s.d
Epilepsy severity (SD) n/a 1.43 (3.77) 3.75 (2.87) n.s.d.
Epilepsy medication n/a 25 % 100 % x2 = 7.88, p = .01
Abbreviations: n/a not applicable, n.s.d. non-significant difference
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British Picture Vocabulary Scale), and a proxy IQ com-
bining these measures was created for 13 of the TSC
participants (data missing on one participant), similar to
previous work in TSC [44]. There was a significant dif-
ference between TSC-only and ASD groups in intellec-
tual ability measured using this parameter, driven by
two ASD participants with severe intellectual disability
(ID) (IQ 20–26). Findings were retained when the ana-
lysis was repeated without the two severe ASD + ID par-
ticipants, and the pattern of results remained the same
across all ERP parameters (results available on request).
There was no significant difference between the TSC-
only and TSC + ASD groups in rates of epilepsy at time
of testing, but there was a significant difference in the
rates of participants currently taking medication for epi-
lepsy whereby all individuals with ASD were taking
medication (Table 1). Where possible, epilepsy severity
was calculated using the Early Childhood Epilepsy Se-
verity Scale (E-CHESS) used in previous studies of TSC
[45, 44] combining information on seizure frequency,
type, duration, treatment and response to treatment
(due to lack of consistent questioning on status epilepti-
cus, this parameter was not included in the scale). There
was no significant difference in epilepsy severity be-
tween the TSC groups (Table 1). Despite group differ-
ences, IQ was not a significant covariate and therefore
was not retained in the analyses (results remained the
same when IQ was included as a covariate; see Add-
itional file 1 for analysis of covariance results). The
study protocol was approved by the Cambridge Local
Research Ethics Committee and the Department of Psy-
chological Sciences Ethical Committee, Birkbeck, Uni-
versity of London.
Task
The stimuli were colour images of three female faces
with direct or averted gaze (looking right or left). These
images were presented either in upright or inverted
orientation on a grey background. Faces subtended
15.8° × 10.2° from a viewing distance of 90 cm. Each trial
began with the presentation of a fixation stimulus that
had a variable inter-trial interval of 800 and 1200 ms to
reduce stimulus repetition effects and ensure the child
could not predict the onset of the face stimulus. Face
stimuli were presented for 500 ms followed by a 500-ms
interval without visual stimulus and were aligned verti-
cally so that the eyes appeared at the same height as the
fixation stimuli, in order to orient attention towards the
eyes. Four hundred eighty trials were presented with
randomized presentation. Participants were asked to
count the appearances of flags among the fixation stim-
uli, in order to stimulate participation and attention, and
participants were also continually monitored by video
recording. This paradigm has been used previously in
ASD and infant samples [21, 35, 42].
EEG recording and processing
Electroencephalography was recorded using a Hydrocel
in control adults and the Geodesic Sensor Net in adults
with TSC, each with 128 electrodes (Electrical Geode-
sics Inc., Eugene, OR). The reference electrode was the
vertex (Cz in the conventional 10/20 system). The elec-
trical signal was digitized at a 250-Hz sampling rate
and amplified with a 0.1- to 100-Hz band-pass filter.
The data were analysed offline using Net Station 4.4
analysis software (Electrical Geodesics Inc.). The con-
tinuous electroencephalographic signal was segmented
to a 1000-ms period and corrected to the 200-ms base-
line prior to stimulus onset. The entire trial was ex-
cluded if data from more than 12 channels were
removed or if the trial contained blinks or other arte-
facts, and missing data for trials with 12 or fewer bad
channels, irrespective of their location, were interpo-
lated. The remaining segments were visually scanned
for bad channels and other artefacts. Participants with
fewer than 20 good trials in any condition were ex-
cluded from further analysis. There were significant dif-
ferences in the number of accepted trials between the
typical controls and the TSC + ASD group across all
conditions (see Additional file 2). Average waveforms
for each individual participant were calculated and re-
referenced to the average.
Based on visual inspection of the grand average and
congruent with previous literature, a montage of elec-
trodes was created where the P1 and N170 components
were maximal in the right and left occipito-temporal
regions, matched over the two EEG recording systems
(Geodesic (TSC): left: 58, 59, 64, 65, 66, 69, 70, 74;
right: 85, 89, 90, 91, 92, 95, 96, 97; Hydrocel (controls):
left: 58, 59, 64, 65, 66, 68, 69, 73; right: 84, 88, 89, 90,
91, 94, 95, 96; see Fig. 1 for montages). Based on visual
inspection of the individual data, the latency windows
were defined as follows: P1 (74–168 ms), N170 (128–
226 ms). A peak-to-peak amplitude was also calculated
between the P1 and N170 amplitude. The component
peak within this latency window was extracted for each
participant, in each condition, for the average of all
channels in the left and in the right hemisphere.
Statistical analysis
A repeated measures ANOVA was conducted on each ERP
parameter (P1 amplitude, P1 latency, N170 amplitude,
N170 latency) with orientation (upright/inverted), gaze
(direct/averted) and hemisphere (left/right) as the within-
subjects factors and group as the between-subjects factor
(control, TSC-only, TSC +ASD). Age was not significant as
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a covariate and therefore was dropped from all analyses.
Post hoc analyses were carried out when necessary using
Fisher’s least significant difference procedure due to the
preliminary nature of the analysis. Effect sizes (Cohen’s d)
were calculated using the difference in the means, divided
by the pooled standard deviation of the data.
Results
See Fig. 2 for grand average ERP responses to each stimulus
by group. See Additional file 1 for amplitude and latency
values for each condition by group and findings of analysis
of covariance with IQ to test the significant differences be-
tween TSC-only and TSC+ASD.
Fig. 1 Montages for a Geodesic net used with TSC adults and b Hydrocel net used with control adults
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P1 amplitude
There was no main effect of age (F(1,24) = 1.70, p= .21) and
age was therefore dropped as a covariate. There was a main
effect of group on P1 amplitude (F(2,24) = 5.75, p = .009).
Post hoc analyses showed that controls had reduced P1
amplitude compared to TSC-only (p= .006, d = 1.36) and
TSC+ASD (p= .02, d = 1.22).
There was no main effect of orientation, but there was
an interaction between group and orientation (F(2,24) =
6.56, p = .005). Significant differences were shown be-
tween TSC + ASD and controls (p = .03, d = 1.33) and
between TSC + ASD and TSC-only (p = .001, d = 1.75).
While controls showed little effect of orientation, TSC-
only showed greater amplitude to inverted faces whereas
TSC + ASD showed greater amplitude to upright faces.
There was an interaction between group and hemi-
sphere (F(2,24) = 4.34, p = .03). There was a significant
difference between controls and TSC-only (p = .02, d =
0.96) and controls and TSC + ASD (p = .02, d = 1.49),
indicating greater amplitude in the right hemisphere
in controls only.
P1 latency
There was a significant interaction between group and
orientation on P1 latency (F(2,24) = 7.79, p = .002). Post
hoc analyses revealed significant differences between
TSC + ASD and controls (p = .001, d = 1.71) and between
TSC + ASD and TSC-only (p = .03, d = 1.15), whereby
controls showed longer latency to inverted faces, TSC-
only showed a similar response to both upright and
inverted faces and TSC + ASD showed a longer latency
to upright faces.
There was a significant interaction between gaze and
hemisphere (F(1,24) = 5.00, p = .04) and a three-way inter-
action between group, gaze and hemisphere (F(2,24) =
4.64, p = .02). Post hoc analyses indicated significant differ-
ences between TSC +ASD and controls (p = .03, d = 0.92)
and between TSC +ASD and TSC-only (p = .01, d = 1.38);
in the left hemisphere, TSC +ASD showed longer latency
to averted gaze whereas in the right hemisphere longer
latency to direct gaze. Controls and TSC-only showed
minimal differences between direct and averted gaze on
P1 latency.
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Fig. 2 Grand mean ERPs to face stimuli for each group in the left and right hemiscalp. Blue represents upright-direct, red represents upright-
averted, green represents inverted-direct, and black represents inverted-averted
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Absolute N170 amplitude
There was a main effect of face orientation (F(1,24) =
24.84, p > .001), indicating enhanced N170 amplitude to
inverted faces compared to upright faces in all three
groups. No other effects were shown (all p > .05).
N170 amplitude relative to P1 amplitude
There was a main effect of orientation (F(1,24) = 17.06,
p < .001), indicating enhanced N170 amplitude to
inverted faces compared to upright faces. There was a
marginally significant interaction between group and
hemisphere (F(2,24) = 3.07, p = .05). Post hoc analyses
showed a marginally significant difference between con-
trols and TSC + ASD (p = .05, d = 1.46), whereby con-
trols showed greater amplitude in the right hemisphere
whereas TSC + ASD showed greater amplitude in the
left hemisphere. There were no other significant effects
(all p > .05).
N170 latency
A number of significant findings were shown for N170
latency. There was a main effect of group (F(2,23) = 4.39,
p = .02), indicating that there was longer N170 latency in
TSC + ASD compared to controls (p = .01, d = 1.46) and
a trend for TSC-only (p = .09, d = 0.96).
There was no significant main effect of orientation
(F(1,24) = 2.14, p = .16) but a significant interaction between
group and orientation emerged (F(2,24) = 5.75, p = .01).
Post hoc analyses revealed a significant difference between
TSC+ASD and controls (p = .002, d = 1.56) and between
TSC+ASD and TSC-only (p = .04, d = 0.95), indicating a
reduced effect of orientation in TSC +ASD. In addition, a
three-way interaction between group, orientation and
hemisphere was found (F(2,24) = 8.16, p = .002). Post hoc
analyses on the different scores revealed a significant differ-
ence between TSC+ASD and controls (p = .001, d = 1.54)
and between TSC+ASD and TSC-only (p = .002, d = 1.52).
Taken together, these effects showed that controls and
TSC-only have a longer N170 latency to inverted
compared to direct faces, whereas adults with TSC +
ASD showed a reduced effect of orientation particu-
larly in the left hemisphere.
There was a main effect of gaze (F(1,24) = 7.02, p = .01),
and a significant interaction between group and gaze was
shown (F(2,24) = 4.00, p = .03). Post hoc analyses indicated
that TSC +ASD had a significantly enhanced effect of
gaze on N170 latency compared to controls (p = .01, d =
1.19). Thus, TSC +ASD showed longer latency to averted
gaze compared to direct gaze.
Discussion
The present study examined neurophysiological re-
sponses to faces in individuals with TSC, with and with-
out ASD, and typical individuals. Results indicate that
adults with TSC and ASD showed altered processing of
faces as indexed by the P1 and N170, which are in line
with previous work in idiopathic ASD populations.
Firstly, this group had slower processing of faces
overall, consistent with previous work [24, 27]. Not-
ably, the face-sensitive N170 component was only al-
tered in TSC + ASD, an effect that was not driven by
low-level visual processing as no latency differences
were observed on the P1 component. This supports
and extends previous findings of prolonged N290 la-
tency in young children with TSC + ASD [41]. This
finding was, however, attenuated when IQ was included as
a covariate, which could reflect insufficient power when
comparing the TSC-only and TSC +ASD groups, or may
indicate prolonged N170 latency is a marker of the co-
morbidity between ASD+ ID in TSC. In addition to ab-
normalities in speed of processing, both TSC groups
showed greater P1 amplitude compared to controls, par-
ticularly TSC-only, suggesting enhanced low-level visual
processing across stimuli. Hyper-sensitivity to perceptual
stimuli is widely reported in ASD [46], and abnormal vis-
ual processing has been hypothesized as causative in the
social problems apparent in ASD [47]. In addition, altered
structural connectivity of visual pathways in the brain has
been demonstrated in children with TSC [48]. As the en-
hanced P1 is demonstrated in both TSC groups, this sug-
gests that the association between TSC and ASD is not
necessarily a result of impairment in early sensory pro-
cessing, supported by intact visual evoked potentials in in-
fants with TSC [49]. Further work is required to examine
whether enhanced P1 amplitude directly relates to sensory
sensitivity. Evidence for altered cortical specialization of
faces in individuals with TSC was indicated for P1 latency
and for TSC +ASD only on peak-to-peak analyses of
N170 amplitude, as shown by greater amplitude in the left
hemisphere or bilaterally in this group. This lack of asym-
metry has previously been reported in children and adults
with ASD [21, 24] and in children with TSC [41]. Given
that bilateral responses to faces are demonstrated in youn-
ger children [50], this may reflect delayed development of
brain regions occurring early in the pathophysiology of
TSC.
Consistent with previous work in ASD [24], typical in-
dividuals showed longer P1 and N170 latency to upright
compared to inverted faces, whereas individuals with
TSC + ASD showed minimal differences or a reversed ef-
fect. The lack of sensitivity to face inversion has been
used to support theories of ‘weak central coherence’ in
ASD, referring to a cognitive bias towards local detail
[51], which could be associated with a reliance on fea-
tures to process faces and/or an impairment in config-
ural face processing. In addition, a lack of sensitivity on
the N170 to gaze direction in typical adults is consistent
with findings demonstrated using the same paradigm
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[35]. Importantly, young children with ASD show en-
hanced activity to direct compared to averted gaze [35],
an effect similar to that shown in typically developing in-
fants [43]. In late childhood, sensitivity to averted gaze
demonstrated in typical controls is not shown in ASD
[21]. The current findings suggest developmental delay
of gaze processing in the TSC + ASD group relative to
typical adults.
Taken together, the findings demonstrate that individ-
uals with TSC generally show abnormal neural responses
to faces at early visual processing stages as indexed by
the P1. Importantly, individuals with TSC that also have
a diagnosis of ASD demonstrate altered processing of
faces as indexed by the face-sensitive N170 component
and altered gaze processing as indexed by both the P1
and N170 components, indicative of brain-based bio-
markers that are specific to ASD and similar to idio-
pathic ASD. The results of the study emphasize the
importance of using syndromic models of ASD to provide
insight on gene-brain-behaviour relationships. Import-
antly, future work in prospective longitudinal studies will
reveal whether specific brain abnormalities or epilepsy-
related factors associated with the pathophysiology of
TSC are causally linked to altered neurophysiological re-
sponses to faces [e.g. 52]. For example, the early arising
structural brain changes occurring in TSC may impact the
development of brain regions implicated in basic visual
processing in TSC, but visual abnormalities might not
be directly related to abnormal face processing in
ASD within TSC. Examining these indices prospect-
ively will reveal the links between early visual pro-
cessing and development of the brain network that
will later specialize for face processing [53, 54]. If
there is a key primary deficit, treatment directed at that
risk pathway may be very effective. By contrast, if there
are multiple primary deficits, then intervention may need
to be targeted at each risk pathway.
The preliminary nature of this work limits power to
make firm conclusions but lays the foundation for future
replication studies in larger samples. Despite the relative
aetiological homogeneity of TSC, it is important to note
that individuals with TSC and ASD are likely to have
other comorbidities, such as epilepsy and intellectual
disability, and therefore a more complex phenotype. We
were not able to gather IQ data in the typical adults,
rendering it difficult to control for the effect of cognitive
ability, although findings were retained when only the
high-functioning adults with TSC were included and
when IQ was included as a covariate. An ideal future
analysis will compare IQ-matched controls with and
without a diagnosis of autism to individuals with TSC
with and without a diagnosis of autism to ascertain the
validity of a phenotypic comparison and support our
conclusions. Future research should be designed that
enables identification of biomarkers that differ between
ASD and ID in TSC. In addition, a significantly higher
proportion of individuals with TSC and ASD were taking
seizure medication; although this was not a significant
covariate, this may confound the findings. Still, the
current findings suggest a level of homology between
syndromic and non-syndromic autism, which warrants
further work to refine the autism phenotype within TSC.
Given the dimensional nature of ASD symptoms, future
work should consider symptom severity scores and their
relationship to candidate biomarkers in addition to a cat-
egorical distinction. Neurophysiological indices of other
cognitive domains need to be explored in order to sup-
port the homology between biomarkers of ASD in TSC
and idiopathic ASD.
Conclusions
This study is the first to characterize candidate elec-
trophysiological biomarkers of face and gaze process-
ing in adults with TSC and ASD. The identification
of aberrant neural correlates of face processing that
are similar reduces the distinction between syndromic
and non-syndromic cases. With additional characterization,
neurophysiological profiles of ASD in TSC may serve as
valuable biomarkers to ultimately elucidate risk pathways to
ASD, in order to direct and monitor specific therapeutic
strategies.
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